US nursing home residents receiving <scp>PCV13</scp> in the <scp>SNF</scp> by recorded pneumococcal vaccination up‐to‐date status, 2014

US nursing home residents receiving PCV13 in the SNF by recorded pneumococcal vaccination up‐to‐date status, 2014–2018

Published:2022-02-25 Issue:6 Volume:70 Page:1726-1733
ISSN:0002-8614
Container-title:Journal of the American Geriatrics Society
language:en
Short-container-title:J American Geriatrics Society

Author:

Bardenheier Barbara H.¹^ORCID,McConeghy Kevin W.¹²^ORCID,Davidson H. Edward³,Gravenstein Stefan¹²⁴

Affiliation:

1. School of Public Health Brown University Providence Rhode Island USA

2. Center on Innovation in Long‐Term Services and Supports Veterans Administration Medical Center Providence Rhode Island USA

3. Insight Therapeutics LLC Virginia USA

4. Department of Medicine Warren Alpert Medical School of Brown University Providence Rhode Island USA

Publisher

Wiley

Subject

Geriatrics and Gerontology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgs.17717

Reference18 articles.

1. Invasive Pneumococcal Disease in Older Adults Residing in Long-Term Care Facilities and in the Community

2. Use of 13‐valent pneumococcal conjugate vaccine and 23‐valent pneumococcal polysaccharide vaccine among adults aged >= 65 years: recommendations of the advisory committee on immunization practices (ACIP);Tomczyk S;Mmwr‐Morbid Mortal W,2014

3. Merck & Co. Inc.FDA Approves Vaxneuvance.https://www.drugs.com/newdrugs/fda‐approves‐vaxneuvance‐pneumococcal‐15‐valent‐conjugate‐vaccine‐prevention‐invasive‐pneumococcal‐5596.html. Published 2021. Accessed 11/01/2021.

4. Prevention of pneumococcal disease: recommendations of the advisory committee on immunization practices (ACIP);Centers for Disease and Prevention;MMWR Morb Mortal Wkly Rep,1997